Kaiser A M, Schultsz C, Kruithof G J, Debets-Ossenkopp Y, Vandenbroucke-Grauls C
VU University Medical Centre, Medical Microbiology and Infection Control, Amsterdam, The Netherlands.
Clin Microbiol Infect. 2004 Nov;10(11):972-9. doi: 10.1111/j.1469-0691.2004.01000.x.
In a prospective survey conducted between May 1998 and September 2001, the prevalence of carriage of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) and gentamicin-resistant Gram-negative bacilli (GGNB) was determined in 1167 patients repatriated from foreign hospitals to The Netherlands. Swab specimens, demographic data and clinical data were obtained during transfer of the patients from the foreign hospitals. The total prevalence of carriage of resistant microorganisms was 18.2%. MRSA was carried by 2.7% of all patients, and by 4.7% of the patients repatriated to a Dutch hospital. Antimicrobial treatment (adjusted odds ratio (OR) 3.4; 95% confidence interval (CI) 1.2-9.7), length of stay in a foreign hospital of > 14 days (adjusted OR 5.4; 95% CI 2.3-12) and artificial ventilation (adjusted OR 8.5; 95% CI 1.8-41) were risk factors for carriage of MRSA. VRE and GGNB were isolated from 2.7% and 14.1% of the patients, respectively. Transfer from Asia, and southern, southeastern and eastern Europe, were risk factors for carriage of GGNB. These carriage rates were high compared to those found in patients in Dutch hospitals, where the rates are < 1% for MRSA, 2% for VRE, and 4.5% for GGNB. The highest risk of acquisition of GGNB was associated with the country from where the patient was repatriated, rather than with the antimicrobial treatment received by the individual patient in the foreign hospital.
在1998年5月至2001年9月进行的一项前瞻性调查中,对1167名从国外医院转回荷兰的患者进行了耐甲氧西林金黄色葡萄球菌(MRSA)、耐万古霉素肠球菌(VRE)和耐庆大霉素革兰阴性杆菌(GGNB)携带情况的测定。在患者从国外医院转运期间获取了拭子标本、人口统计学数据和临床数据。耐药微生物的总体携带率为18.2%。所有患者中2.7%携带MRSA,转回荷兰医院的患者中4.7%携带MRSA。抗菌治疗(调整优势比(OR)3.4;95%置信区间(CI)1.2 - 9.7)、在国外医院住院时间>14天(调整OR 5.4;95%CI 2.3 - 12)和人工通气(调整OR 8.5;95%CI 1.8 - 41)是携带MRSA的危险因素。VRE和GGNB分别从2.7%和14.1%的患者中分离出来。从亚洲以及南欧、东南欧和东欧转回是携带GGNB的危险因素。与荷兰医院患者的携带率相比,这些携带率较高,荷兰医院患者中MRSA的携带率<1%,VRE为2%,GGNB为4.5%。获得GGNB的最高风险与患者转回的国家有关,而不是与患者在国外医院接受的抗菌治疗有关。